胸腔內科

Medicine & Life Sciences

1. A549 Cells 16%
2. Adenocarcinoma of Lung 31%
3. Adrenal Cortex Hormones 8%
4. Air Pollution 32%
5. Apoptosis 16%
6. Asthma 35%
7. Autophagy 11%
8. Biomarkers 10%
9. butylidenephthalide 9%
10. Carbon 11%
11. CCAAT-Enhancer-Binding Proteins 9%
12. Cell Survival 8%
13. China 11%
14. Chronic Obstructive Pulmonary Disease 48%
15. Cohort Studies 34%
16. Complement Factor B 9%
17. Confidence Intervals 15%
18. Connective Tissue Growth Factor 32%
19. Coronavirus 13%
20. Cyclooxygenase 2 19%
21. Cytokines 8%
22. Diabetes Mellitus 8%
23. Disintegrins 9%
24. Drug Resistance 8%
25. Drug Therapy 9%
26. Emphysema 8%
27. Endothelin-1 9%
28. Epithelial Cells 22%
29. ErbB Receptors 32%
30. Extracellular Signal-Regulated MAP Kinases 12%
31. Fibroblasts 20%
32. Fibrosis 14%
33. Fluoroquinolones 13%
34. Health 8%
35. Heart Rate 12%
36. Histone Deacetylase Inhibitors 9%
37. Hong Kong 12%
38. Incidence 10%
39. Inflammation 20%
40. Intensive Care Units 10%
41. Interleukin-6 13%
42. Interleukin-8 23%
43. Luciferases 10%
44. Lung 65%
45. Lung Neoplasms 37%
46. Machine Learning 12%
47. Macrophages 16%
48. Malignant Pleural Effusion 9%
49. Meta-Analysis 17%
50. Metals 11%
51. Mortality 10%
52. Multidrug-Resistant Tuberculosis 45%
53. Mutation 19%
54. Mycobacterium tuberculosis 21%
55. Nanoparticles 16%
56. National Health Programs 10%
57. Neoplasm Metastasis 10%
58. Neoplasms 18%
59. Non-Small Cell Lung Carcinoma 36%
60. Obstructive Sleep Apnea 17%
61. Occupational Groups 11%
62. Odds Ratio 12%
63. Ovalbumin 9%
64. p38 Mitogen-Activated Protein Kinases 8%
65. Particulate Matter 58%
66. Peptidoglycan 12%
67. Pharmaceutical Preparations 17%
68. Phosphatidylinositol 3-Kinase 10%
69. Phosphorylation 16%
70. Phosphotransferases 13%
71. Plasminogen Activator Inhibitor 1 18%
72. Platelet Activation 10%
73. Pleural Effusion 15%
74. Pneumonia 23%
75. Polycyclic Aromatic Hydrocarbons 18%
76. Population 20%
77. Protein-Tyrosine Kinases 25%
78. Proteins 14%
79. Pulmonary Tuberculosis 28%
80. Rheumatoid Arthritis 9%
81. Rifampin 11%
82. Single-Chain Antibodies 9%
83. Sleep 13%
84. Small Interfering RNA 11%
85. Soot 14%
86. Survival 12%
87. Systematic Reviews 11%
88. Systemic Lupus Erythematosus 11%
89. Taiwan 100%
90. Therapeutics 22%
91. Thrombin 27%
92. Toxicology 8%
93. Transcription Factor AP-1 20%
94. Transforming Growth Factors 10%
95. Tuberculosis 83%
96. Tumor Necrosis Factor-alpha 9%
97. Vehicle Emissions 15%
98. Welding 8%
99. Zinc Oxide 13%